CYP3A4 and inflammatory bowel disease: Zhang et al. [62] demonstrated that Tan IIA is an efficacious PXR agonist and able to increase CYP3A4 mRNA levels, and its protein expression was mediated by the transactivation of PXR in inflammatory bowel disease.